THRX
Theseus Pharmaceuticals, Inc. Common Stock
THRX
THRX
Delisted
THRX was delisted on the 13th of February, 2024.
63 hedge funds and large institutions have $95.5M invested in Theseus Pharmaceuticals, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 19 increasing their positions, 21 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding in top 10
Funds holding in top 10: →
74% less capital invested
Capital invested by funds: $374M → $95.5M (-$278M)
Holders
63
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$4.27M | |
| 2 | +$1.41M | |
| 3 | +$1.29M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$696K |
| 5 |
AAA
Affinity Asset Advisors
New York
|
+$432K |
Top Sellers
| 1 | -$18.2M | |
| 2 | -$13.1M | |
| 3 | -$7.18M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$5.93M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$5.64M |